<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Ludvigsen Foged | Activity</title>
	<link>https://www.catswannabecats.com/members/fingerjudo3/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/fingerjudo3/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Ludvigsen Foged.</description>
	<lastBuildDate>Mon, 06 Jul 2026 08:03:58 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">749d18c7debe4eff07dbe02703f7f7ba</guid>
				<title>Ludvigsen Foged posted an update: Specifically, we show that multiwavelength resonant modes [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/19561/</link>
				<pubDate>Thu, 05 Jun 2025 07:58:12 -0400</pubDate>

									<content:encoded><![CDATA[<p>Specifically, we show that multiwavelength resonant modes with intensity enhancement exceeding three orders of magnitude are possible with w  less then  30 nm and 300 nm  less then  d  less then  900 nm for a range of fixed values of L. This study presents a novel paradigm of deep-subwavelength adiabatically-coupled width-graded gratings-il&hellip;<span class="activity-read-more" id="activity-read-more-19561"><a href="https://www.catswannabecats.com/activity/p/19561/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9976d93c1a4582a9e00c7f608b965ba2</guid>
				<title>Ludvigsen Foged posted an update: 8% and 76.9%, respectively), and thoracic and breast trials [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/11255/</link>
				<pubDate>Sun, 01 Jun 2025 05:28:47 -0400</pubDate>

									<content:encoded><![CDATA[<p>8% and 76.9%, respectively), and thoracic and breast trials used the fewest (18.8% and 37.5%, respectively). The EQ-5D family of questionnaires was the most commonly used PROs, used in 22.8% of trials included. The literature review demonstrated a pattern of increased publication of PRO data alongside survival endpoints in manuscripts derived from&hellip;<span class="activity-read-more" id="activity-read-more-11255"><a href="https://www.catswannabecats.com/activity/p/11255/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b559156dad974bbc0120b8a99a17c27c</guid>
				<title>Ludvigsen Foged became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/10614/</link>
				<pubDate>Sun, 01 Jun 2025 02:03:07 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>